Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Pharmacoeconomics
|
November 23, 2018
Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal
Lindsay Claxton, Joanne O'Connor, Nerys Woolacott, et al.
Pharmacoeconomics
|
October 10, 2018
Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal
Lindsay Claxton, Joanne O'Connor, Nerys Woolacott, et al.
Environmental Research
|
July 22, 2023
Impacts of net zero policies on air quality in a metropolitan area of the United Kingdom: Towards world health organization air quality guidelines
Jian Zhong, James Robert Hodgson, William James Bloss, et al.
Organic & Biomolecular Chemistry
|
August 22, 2003
A stereodivergent, two-directional synthesis of stereoisomeric C-linked disaccharide mimetics
Michael Harding, Robert Hodgson, Tahir Majid, et al.
Pharmacoeconomics
|
October 28, 2016
Simulation Modelling in Ophthalmology: Application to Cost Effectiveness of Ranibizumab and Aflibercept for the Treatment of Wet Age-Related Macular Degeneration in the United Kingdom
Lindsay Claxton, Robert Hodgson, Matthew Taylor, et al.
Pharmacoeconomics
|
March 26, 2017
Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Philip Morgan, Nerys Woolacott, Mousumi Biswas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 2, 2022
The Cost-Effectiveness of Selective Internal Radiation Therapies Compared With Sorafenib for Treating Advanced Unresectable Hepatocellular Carcinoma in the United Kingdom
Lindsay Claxton, Matthew Walton, Sahar Sharif-Hurst, et al.
Pharmacoeconomics
|
December 3, 2024
Application of Multi-level Network Meta-Regression in the NICE Technology Appraisal of Quizartinib for Induction, Consolidation and Maintenance Treatment of Newly Diagnosed FLT3-ITD-Positive Acute Myeloid Leukaemia: An External Assessment Group Perspective
Sarah J Nevitt, David M Phillippo, Robert Hodgson, et al.
Health Technology Assessment (Winchester, England)
|
February 9, 2026
Artificial Intelligence technologies for assessing skin lesions for referral on the urgent suspected cancer pathway to detect benign lesions and reduce secondary care specialist appointments: early value assessment
Matthew Walton, Alexis Llewellyn, Eleonora Uphoff, et al.
Organic & Biomolecular Chemistry
|
August 30, 2003
Exploiting predisposition in the stereoselective synthesis of mono-, bi- and tetracyclic oxygen heterocycles: equilibration between, and trapping of, alternative di- and tetraacetals
Stephen Bartlett, Robert Hodgson, Joanne M Holland, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Pharmacoeconomics
|
November 23, 2018
Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal
Lindsay Claxton, Joanne O'Connor, Nerys Woolacott, et al.
Pharmacoeconomics
|
October 10, 2018
Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal
Lindsay Claxton, Joanne O'Connor, Nerys Woolacott, et al.
Environmental Research
|
July 22, 2023
Impacts of net zero policies on air quality in a metropolitan area of the United Kingdom: Towards world health organization air quality guidelines
Jian Zhong, James Robert Hodgson, William James Bloss, et al.
Organic & Biomolecular Chemistry
|
August 22, 2003
A stereodivergent, two-directional synthesis of stereoisomeric C-linked disaccharide mimetics
Michael Harding, Robert Hodgson, Tahir Majid, et al.
Pharmacoeconomics
|
October 28, 2016
Simulation Modelling in Ophthalmology: Application to Cost Effectiveness of Ranibizumab and Aflibercept for the Treatment of Wet Age-Related Macular Degeneration in the United Kingdom
Lindsay Claxton, Robert Hodgson, Matthew Taylor, et al.
Pharmacoeconomics
|
March 26, 2017
Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Philip Morgan, Nerys Woolacott, Mousumi Biswas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 2, 2022
The Cost-Effectiveness of Selective Internal Radiation Therapies Compared With Sorafenib for Treating Advanced Unresectable Hepatocellular Carcinoma in the United Kingdom
Lindsay Claxton, Matthew Walton, Sahar Sharif-Hurst, et al.
Pharmacoeconomics
|
December 3, 2024
Application of Multi-level Network Meta-Regression in the NICE Technology Appraisal of Quizartinib for Induction, Consolidation and Maintenance Treatment of Newly Diagnosed FLT3-ITD-Positive Acute Myeloid Leukaemia: An External Assessment Group Perspective
Sarah J Nevitt, David M Phillippo, Robert Hodgson, et al.
Health Technology Assessment (Winchester, England)
|
February 9, 2026
Artificial Intelligence technologies for assessing skin lesions for referral on the urgent suspected cancer pathway to detect benign lesions and reduce secondary care specialist appointments: early value assessment
Matthew Walton, Alexis Llewellyn, Eleonora Uphoff, et al.
Organic & Biomolecular Chemistry
|
August 30, 2003
Exploiting predisposition in the stereoselective synthesis of mono-, bi- and tetracyclic oxygen heterocycles: equilibration between, and trapping of, alternative di- and tetraacetals
Stephen Bartlett, Robert Hodgson, Joanne M Holland, et al.
Page
of 7